Join to View Full Profile
Elm and Carlton Streets RPCI Clinical Practice PlanBuffalo, NY 14263
Phone+1 716-845-2300
Fax+1 716-898-3279
Dr. Gandhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2015 - 2018- University at BuffaloResidency, Internal Medicine, 2012 - 2015
Lady Hardinge Medical CollegeClass of 2011
Certifications & Licensure
GA State Medical License 2024 - 2026
NY State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer Start of enrollment: 2019 Jan 09
- Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer Start of enrollment: 2019 Dec 06
- Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer Start of enrollment: 2022 Dec 19
- Join now to see all
Publications & Presentations
PubMed
- Breast biomarkers evolution between primary and distant metastasis: incidence and significance.Maha Khedr, Shipra Gandhi, Arya Mariam Roy, Malak Alharbi, Anthony George
Histopathology. 2025-04-01 - HSR25-170: Investigating Socioeconomic and Racial Disparities in Pathologic Response and Survival Outcomes in Triple-Negative Breast Cancer Post-Neoadjuvant Chemothera...Zunairah Shah, Malak Alharbi, Mengyu Fang, Han Yu, Shipra Gandhi
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 1 citationsUnder-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.Alfredo V Chua Jr, Jennifer Delmerico, Haiyang Sheng, Xin-Wei Huang, Emily Liang
JCO Oncology Practice. 2025-03-01
Press Mentions
Arya Mariam Roy on Real-World Outcomes with Sacituzumab Govitecan in Metastatic TNBCJanuary 21st, 2025- Roswell Experts Offer Lifestyle Guidance for Breast Cancer SurvivorsDecember 11th, 2024
- AIM ImmunoTech Announces Data Pubished on Part 1 Study on AmpligenNovember 19th, 2024
- Join now to see all
Grant Support
- Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancerROSWELL PARK CANCER INSTITUTE CORP2024–2029
- Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancerROSWELL PARK CANCER INSTITUTE CORP2024–2029
- Identifying the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancerROSWELL PARK CANCER INSTITUTE CORP2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
